1
|
Mitrakas A, Stathopoulou MEK, Mikra C, Konstantinou C, Rizos S, Malichetoudi S, Koumbis AE, Koffa M, Fylaktakidou KC. Synthesis of 2-Amino- N'-aroyl(het)arylhydrazides, DNA Photocleavage, Molecular Docking and Cytotoxicity Studies against Melanoma CarB Cell Lines. Molecules 2024; 29:647. [PMID: 38338390 PMCID: PMC10856246 DOI: 10.3390/molecules29030647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2023] [Revised: 01/21/2024] [Accepted: 01/22/2024] [Indexed: 02/12/2024] Open
Abstract
Diacylhydrazine bridged anthranilic acids with aryl and heteroaryl domains have been synthesized as the open flexible scaffold of arylamide quinazolinones in order to investigate flexibility versus rigidity towards DNA photocleavage and sensitivity. Most of the compounds have been synthesized via the in situ formation of their anthraniloyl chloride and subsequent reaction with the desired hydrazide and were obtained as precipitates, in moderate yields. All compounds showed high UV-A light absorption and are eligible for DNA photocleavage studies under this "harmless" irradiation. Despite their reduced UV-B light absorption, a first screening indicated the necessity of a halogen at the p-position in relation to the amine group and the lack of an electron-withdrawing group on the aryl group. These characteristics, in general, remained under UV-A light, rendering these compounds as a novel class of UV-A-triggered DNA photocleavers. The best photocleaver, the compound 9, was active at concentrations as low as 2 μΜ. The 5-Nitro-anthranilic derivatives were inactive, giving the opposite results to their related rigid quinazolinones. Molecular docking studies with DNA showed possible interaction sites, whereas cytotoxicity experiments indicated the iodo derivative 17 as a potent cytotoxic agent and the compound 9 as a slight phototoxic compound.
Collapse
Affiliation(s)
- Achilleas Mitrakas
- Laboratory of Cellular Biology, Molecular Biology and Genetics Department, Democritus University of Thrace, University Campus, 68100 Alexandroupolis, Greece; (A.M.); (S.M.); (M.K.)
| | - Maria-Eleni K. Stathopoulou
- Laboratory of Organic, Bioorganic and Natural Product Chemistry, Molecular Biology and Genetics Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (M.-E.K.S.); (C.K.)
| | - Chrysoula Mikra
- Laboratory of Organic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.M.); (A.E.K.)
| | - Chrystalla Konstantinou
- Laboratory of Organic, Bioorganic and Natural Product Chemistry, Molecular Biology and Genetics Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (M.-E.K.S.); (C.K.)
| | - Stergios Rizos
- Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA 02138, USA;
| | - Stella Malichetoudi
- Laboratory of Cellular Biology, Molecular Biology and Genetics Department, Democritus University of Thrace, University Campus, 68100 Alexandroupolis, Greece; (A.M.); (S.M.); (M.K.)
| | - Alexandros E. Koumbis
- Laboratory of Organic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.M.); (A.E.K.)
| | - Maria Koffa
- Laboratory of Cellular Biology, Molecular Biology and Genetics Department, Democritus University of Thrace, University Campus, 68100 Alexandroupolis, Greece; (A.M.); (S.M.); (M.K.)
| | - Konstantina C. Fylaktakidou
- Laboratory of Organic, Bioorganic and Natural Product Chemistry, Molecular Biology and Genetics Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (M.-E.K.S.); (C.K.)
- Laboratory of Organic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.M.); (A.E.K.)
| |
Collapse
|
2
|
Liu C, Jalagam PR, Feng J, Wang W, Raja T, Sura MR, Manepalli RKVLP, Aliphedi BR, Medavarapu S, Nair SK, Muthalagu V, Natesan R, Gupta A, Beno B, Panda M, Ghosh K, Shukla JK, Sale H, Haldar P, Kalidindi N, Shah D, Patel D, Mathur A, Ellsworth BA, Cheng D, Regueiro-Ren A. Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3. J Med Chem 2022; 65:11084-11099. [PMID: 35969688 DOI: 10.1021/acs.jmedchem.2c00517] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Galectin-3 (Gal-3), a member of the β-galactoside-binding protein family, is implicated in a wide variety of human diseases. Identification of Gal-3 inhibitors with the right combination of potency (against both human and mouse Gal-3) and pharmacokinetic properties to fully evaluate the potential of Gal-3 for therapeutic intervention has been a major challenge due to the characteristics of its binding pocket: high hydrophilicity and key structural differences between human Gal-3 and the mouse ortholog. We report the discovery of a novel series of monosaccharide-based, highly potent, and orally bioavailable inhibitors of human and mouse Gal-3. The novel monosaccharide derivatives proved to be selective for Gal-3, the only member of the chimeric type of galectins, over Gal-1 and Gal-9, representative of the prototype and tandem-repeat type of galectins, respectively. The proposed binding mode for the newly identified ligands was confirmed by an X-ray cocrystal structure of a representative analogue bound to Gal-3 protein.
Collapse
Affiliation(s)
- Chunjian Liu
- Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Prasada Rao Jalagam
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Jianxin Feng
- Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Wei Wang
- Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Thiruvenkadam Raja
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | | | | | - Bheema Reddy Aliphedi
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Santosh Medavarapu
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Satheesh K Nair
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | | | - Ramesh Natesan
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Anuradha Gupta
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Brett Beno
- Department of Computer-Aided Drug Design & Molecular Analytics, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Manoranjan Panda
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Kaushik Ghosh
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | | | - Harinath Sale
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Priyanka Haldar
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | | | - Devang Shah
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India
| | - Dipal Patel
- Department of Metabolism and Pharmacokinetics, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Arvind Mathur
- Department of Discovery Synthesis, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Bruce A Ellsworth
- Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Dong Cheng
- Department of Cardiovascular and Fibrosis Discovery Biology, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| | - Alicia Regueiro-Ren
- Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States
| |
Collapse
|
3
|
Tereshchenko OD, Perebiynis MY, Knysh IV, Vasylets OV, Sorochenko AA, Slobodyanyuk EY, Rusanov EB, Borysov OV, Kolotilov SV, Ryabukhin SV, Volochnyuk DM. Electrochemical Scaled‐up Synthesis of Cyclic Enecarbamates as Starting Materials for Medicinal Chemistry Relevant Building Bocks. Adv Synth Catal 2020. [DOI: 10.1002/adsc.202000450] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
| | | | | | | | | | - Eugeniy Y. Slobodyanyuk
- Enamine Ltd 78 Chervonotkatska str. Kyiv Ukraine
- Institute of Organic ChemistryNational Academy of Sciences of Ukraine 5 Murmanska str. Kyiv Ukraine
| | - Eduard B. Rusanov
- Institute of Organic ChemistryNational Academy of Sciences of Ukraine 5 Murmanska str. Kyiv Ukraine
| | - Oleksandr V. Borysov
- Enamine Ltd 78 Chervonotkatska str. Kyiv Ukraine
- Institute of Organic ChemistryNational Academy of Sciences of Ukraine 5 Murmanska str. Kyiv Ukraine
| | - Sergey V. Kolotilov
- L. V. Pisarzhevskii Institute of Physical ChemistryNational Academy of Sciences of Ukraine 31 Nauki ave. Kyiv Ukraine
| | - Sergey V. Ryabukhin
- Enamine Ltd 78 Chervonotkatska str. Kyiv Ukraine
- Taras Shevchenko National University of Kyiv 60 Volodymyrska str. Kyiv Ukraine
| | - Dmitriy M. Volochnyuk
- Enamine Ltd 78 Chervonotkatska str. Kyiv Ukraine
- Institute of Organic ChemistryNational Academy of Sciences of Ukraine 5 Murmanska str. Kyiv Ukraine
- Taras Shevchenko National University of Kyiv 60 Volodymyrska str. Kyiv Ukraine
| |
Collapse
|
4
|
Tzara A, Xanthopoulos D, Kourounakis AP. Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies. ChemMedChem 2020; 15:392-403. [PMID: 32017384 DOI: 10.1002/cmdc.201900682] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2019] [Revised: 01/21/2020] [Indexed: 12/14/2022]
Abstract
Morpholine is a frequently used heterocycle in medicinal chemistry and a privileged structural component of bioactive molecules. This is mainly due to its contribution to a plethora of biological activities as well as to an improved pharmacokinetic profile of such bioactive molecules. The synthesis of morpholines is a subject of much study due to their biological and pharmacological importance, with the last such review being published in 2013. Here, an overview of the main approaches toward morpholine synthesis or functionalization is presented, emphasizing on novel work which has not been reviewed so far. This review is an update on synthetic strategies leading to easily accessible libraries of bioactives which are of interest for drug discovery projects.
Collapse
Affiliation(s)
- Ariadni Tzara
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771, Athens, Greece
| | - Dimitrios Xanthopoulos
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771, Athens, Greece
| | - Angeliki P Kourounakis
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771, Athens, Greece
| |
Collapse
|
5
|
Yalazan H, Barut B, Ertem B, Yalçın CÖ, Ünver Y, Özel A, Ömeroğlu İ, Durmuş M, Kantekin H. DNA interaction and anticancer properties of new peripheral phthalocyanines carrying tosylated 4-morpholinoaniline units. Polyhedron 2020. [DOI: 10.1016/j.poly.2019.114319] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
6
|
Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR). Bioorg Chem 2020; 96:103578. [PMID: 31978684 DOI: 10.1016/j.bioorg.2020.103578] [Citation(s) in RCA: 78] [Impact Index Per Article: 19.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 12/09/2019] [Accepted: 01/09/2020] [Indexed: 12/15/2022]
Abstract
Morpholine is a versatile moiety, a privileged pharmacophore and an outstanding heterocyclic motif with wide ranges of pharmacological activities due to different mechanisms of action. The ability of morpholine to enhance the potency of the molecule through molecular interactions with the target protein (kinases) or to modulate the pharmacokinetic properties propelled medicinal chemists and researchers to synthesize morpholine ring by the efficient ways and to incorporate this moiety to develop various lead compounds with diverse therapeutic activities. The present review primarily focused on discussing the most promising synthetic leads containing morpholine ring along with structure-activity relationship (SAR) to reveal the active pharmacophores accountable for anticancer, anti-inflammatory, antiviral, anticonvulsant, antihyperlipidemic, antioxidant, antimicrobial and antileishmanial activity. This review outlines some of the recent effective chemical synthesis for morpholine ring. The review also highlighted the metabolic liability of some clinical drugs containing this nucleus and various researches on modified morpholine to enhance the metabolic stability of drugs as well. Drugs bearing morpholine ring and those under clinical trials are also mentioned with the role of morpholine and their mechanism of action. This review will provide the necessary knowledge base to the medicinal chemists in making strategic structural changes in designing morpholine derivatives.
Collapse
|
7
|
Brandão P, Pineiro M, Pinho e Melo TMVD. Flow Chemistry: Towards A More Sustainable Heterocyclic Synthesis. European J Org Chem 2019. [DOI: 10.1002/ejoc.201901335] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Pedro Brandão
- CQC and Department of Chemistry; University of Coimbra; 3004-535 Coimbra Portugal
- Centro de Química de Évora; Institute for Research and Advanced Studies; University of Évora; 7000 Évora Portugal
| | - Marta Pineiro
- CQC and Department of Chemistry; University of Coimbra; 3004-535 Coimbra Portugal
| | | |
Collapse
|
8
|
Argüello‐Velasco RO, Sánchez‐Muñoz GK, Viveros‐Ceballos JL, Ordóñez M, Kafarski P. A Straightforward Synthesis of Six‐Membered‐Ring Heterocyclic α‐Aminophosphonic Acids from
N
‐Acyliminium Ions. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3593] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Rubén Oswaldo Argüello‐Velasco
- Centro de Investigaciones Químicas‐IICBAUniversidad Autónoma del Estado de Morelos Avenue Universidad 1001 62209 Cuernavaca Morelos Mexico
| | - Grecia Katherine Sánchez‐Muñoz
- Centro de Investigaciones Químicas‐IICBAUniversidad Autónoma del Estado de Morelos Avenue Universidad 1001 62209 Cuernavaca Morelos Mexico
| | - José Luis Viveros‐Ceballos
- Centro de Investigaciones Químicas‐IICBAUniversidad Autónoma del Estado de Morelos Avenue Universidad 1001 62209 Cuernavaca Morelos Mexico
| | - Mario Ordóñez
- Centro de Investigaciones Químicas‐IICBAUniversidad Autónoma del Estado de Morelos Avenue Universidad 1001 62209 Cuernavaca Morelos Mexico
| | - Pawel Kafarski
- Department of Bioorganic ChemistryWroclaw University of Science and Technology Wybrzeże Wyspiańskiego 27 50‐370 Wrocław Poland
| |
Collapse
|
9
|
Kärkäs MD. Electrochemical strategies for C-H functionalization and C-N bond formation. Chem Soc Rev 2018; 47:5786-5865. [PMID: 29911724 DOI: 10.1039/c7cs00619e] [Citation(s) in RCA: 588] [Impact Index Per Article: 98.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Conventional methods for carrying out carbon-hydrogen functionalization and carbon-nitrogen bond formation are typically conducted at elevated temperatures, and rely on expensive catalysts as well as the use of stoichiometric, and perhaps toxic, oxidants. In this regard, electrochemical synthesis has recently been recognized as a sustainable and scalable strategy for the construction of challenging carbon-carbon and carbon-heteroatom bonds. Here, electrosynthesis has proven to be an environmentally benign, highly effective and versatile platform for achieving a wide range of nonclassical bond disconnections via generation of radical intermediates under mild reaction conditions. This review provides an overview on the use of anodic electrochemical methods for expediting the development of carbon-hydrogen functionalization and carbon-nitrogen bond formation strategies. Emphasis is placed on methodology development and mechanistic insight and aims to provide inspiration for future synthetic applications in the field of electrosynthesis.
Collapse
Affiliation(s)
- Markus D Kärkäs
- Department of Chemistry, Organic Chemistry, KTH Royal Institute of Technology, SE-100 44 Stockholm, Sweden.
| |
Collapse
|
10
|
Demirci S. Synthesis of Thiazole Derivatives as Antimicrobial Agents by Green Chemistry Techniques. JOURNAL OF THE TURKISH CHEMICAL SOCIETY, SECTION A: CHEMISTRY 2018. [DOI: 10.18596/jotcsa.375716] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
11
|
Parveen H, Alsharif MA, Alahmdi MI, Mukhtar S, Azam A. Novel Pyrimidine-based Ferrocenyl substituted Organometallic Compounds: Synthesis, Characterization and Biological Evaluation. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4261] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Humaira Parveen
- Department of Chemistry, Faculty of Science; University of Tabuk; Tabuk 71491 Kingdom of Saudi Arabia
| | - Meshari A. Alsharif
- Department of Chemistry, Faculty of Science; University of Tabuk; Tabuk 71491 Kingdom of Saudi Arabia
| | - Mohammed I. Alahmdi
- Department of Chemistry, Faculty of Science; University of Tabuk; Tabuk 71491 Kingdom of Saudi Arabia
| | - Sayeed Mukhtar
- Department of Chemistry, Faculty of Science; University of Tabuk; Tabuk 71491 Kingdom of Saudi Arabia
| | - Amir Azam
- Department of Chemistry; Jamia Millia Islamia; Jamia Nagar New Delhi 110025 India
| |
Collapse
|
12
|
Yan M, Kawamata Y, Baran PS. Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance. Chem Rev 2017; 117:13230-13319. [PMID: 28991454 PMCID: PMC5786875 DOI: 10.1021/acs.chemrev.7b00397] [Citation(s) in RCA: 1881] [Impact Index Per Article: 268.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Electrochemistry represents one of the most intimate ways of interacting with molecules. This review discusses advances in synthetic organic electrochemistry since 2000. Enabling methods and synthetic applications are analyzed alongside innate advantages as well as future challenges of electroorganic chemistry.
Collapse
Affiliation(s)
| | | | - Phil S. Baran
- Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States
| |
Collapse
|